Drug Discovery and Development: The Role of Artificial Intelligence in Drug Repurposing

Click to increase image sizeClick to decrease image size

Financial disclosure

M Aljofan is supported by Nazarbayev University CRP grant (OPCRP2021006) and A Gaipov is supported by FDCRGP (201223FD2604). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

Competing interests disclosure

The authors have no competing interests or relevant affiliations with any organization or entity with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

Writing disclosure

No writing assistance was utilized in the production of this manuscript.

Additional information

Funding

M Aljofan is supported by Nazarbayev University CRP grant (OPCRP2021006) and A Gaipov is supported by FDCRGP (201223FD2604). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.